Forest Laboratories Inc. $89.58

down -0.71


17/4/2014 06:40 PM  |  NYSE : FRX  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get FRX Trend Analysis - it has outperformed the S&P 500 by 132%

Partner Headlines

  1. Bill Nygren Comments on Forest Laboratories

    GuruFocus
  2. Bill Nygren Comments on Forest Laboratories

    GuruFocus
  3. Biotech IPOs Adamas, Cerulean Slump In Trading Debut

    IBD
  4. US Stock Futures Up; All Eyes On Fed Minutes

    Benzinga
  5. Meda Rejects Mylan's Bid

    IBD
  6. Mylan Bid Gets Rejected, But Generic-Drugmaker Rises

    IBD
  7. Mylan Rejected In Bid To Acquire Sweden's Meda

    IBD
  8. US Stock Futures Up Ahead Of Chicago PMI

    Benzinga
  9. Big Deals Drive Investment Banks, Brokers, Near Highs

    IBD
  10. Forest Laboratories' Recovery

    GuruFocus
  11. Benzinga's Top Downgrades

    Benzinga
  12. Diamond Hill Capital Comments on Forest Laboratories Inc.

    GuruFocus
  13. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  14. Drugmakers Actavis, Biogen, Valeant Hold Near Highs

    IBD
  15. Valeant Beats Q4 Estimates, Talks Buyout Strategy

    IBD
  16. Pharma ETFs On The Move Again (IHE, PJP, PPH, ACT, FRX)

    Benzinga
  17. Shares of M&A Bidders Enjoy Rare Burst of Buying

    FoxBusiness
  18. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD
  19. Medicals Among Top 20 Groups, Retailers Near Bottom

    IBD
  20. Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends Winning Streak

    Benzinga
  21. #PreMarket Primer: Wednesday, February 19: Tesla Earnings Expected Today

    Benzinga
  22. Actavis, Forest In $25 Bil Deal

    IBD
  23. Benzinga's M&A Chatter for Tuesday February 18, 2014

    Benzinga
  24. Actavis' Buyout Of Forest Creating Spec Pharma Giant

    IBD
  25. Market Wrap For February 18: Dow Finishes Lower, Nasdaq Still Hot

    Benzinga
  26. Stocks End With Mixed Results; Ubiquiti, Sungy Surge

    IBD
  27. Mid-Afternoon Market Update: Actavis Acquisition of Forest Labs Dominates ...

    Benzinga
  28. Stocks Mostly Higher In Afternoon; Qihoo Hits New High

    IBD
  29. Broad Stock Indexes Gain; Coke Weighs On Dow

    IBD
  30. Mid-Day Market Update: US Stocks Mostly Higher; Forest Laboratories Shares ...

    Benzinga
  31. Mid-Morning Market Update: Markets Mixed; Coca-Cola Posts Decline In Profit

    Benzinga
  32. Benzinga's Volume Movers

    Benzinga
  33. Stocks Struggle In Mixed Trade; Salix, HollySys Advance

    IBD
  34. Top Trending Tickers On StockTwits For February 18

    Benzinga
  35. Stocks Hitting 52-Week Highs

    Benzinga
  36. Stocks Futures Point Higher; Actavis To Acquire Forest Labs

    IBD
  37. Actavis to Acquire Forest Labs for ~$25B in Equity, Cash; Both Stocks Surge ...

    Benzinga
  38. UPDATE: Morgan Stanley Upgrades Forest Laboratories Ahead of Further Financial ...

    Benzinga
  39. Benzinga's Top #PreMarket Gainers

    Benzinga
  40. Stock Futures Jump Ahead of Factory Data

    FoxBusiness
  41. Wall Street Ticks Higher Despite Disappointing Data

    FoxBusiness
  42. #PreMarket Primer: Tuesday, February 18: Big Merger Deals In The Works

    Benzinga
  43. Actavis to Buy Forest Labs in $25B Deal

    FoxBusiness
  44. US Stock Futures Flat Ahead Of Coca-Cola Earnings, Housing Data

    Benzinga
  45. GuruFocus Guru of the Year Carl Icahn's Top Fourth Quarter Holdings

    GuruFocus
  46. Vanguard Health Care Fund's Top Five

    GuruFocus
  47. Specialty Pharma Gets Bigger

    IBD
  48. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  49. Meet 2 Estimate Beaters That've Reported, 2 That Will

    IBD
  50. Intrexon: Living Better Through Synthetic Biology?

    IBD
Trading Center